The Patent Fight

What this pack runs.

A patent is a right to keep others out for a term, granted before anyone has tested it. It becomes a decision when another company sells what it covers and you have to choose: sue, settle, or license. The meeting prices one of the three, how strong the case is, and that is an input to the first route that says nothing about the other two, which already have prices written on them. This pack turns it into two annuities and a chance. What a win is worth is the protection from the ruling to expiry, at what the patent protects, because the accused sells through every year of the fight and three of the nine cases took seven, eleven, and fifteen years. What a loss would release is what else the patent holds off, the royalties other licensees pay and the rivals it deters, all of which is exposed the day the patent goes in front of a judge; two of the five plaintiffs in the set lost the patents they sued on. What the fight is worth is the win at your chance, less the loss at the rest, less the fee. Set it beside the royalty and the lump sum on the table and the decision reduces to the break-even win chance, the chance of winning at which suing beats licensing, with its distance from counsel's figure as the number a board can watch. The second distance is the break-even years to a ruling. The Model tab sweeps the chance from none to certain, because it is the one figure in the meeting that arrives as an adjective. It stops on two halts: no one has put the chance in writing from counsel who will not run the fight, and no one has priced what else the patent holds off. Both accept a deliberate zero, and each zero is its own reading: nothing on the table, and a patent that holds off nothing else.

The casebooks these cases come from.

The pack reads nine sourced decisions through the framework. They are drawn from these casebooks, each one a set of verified records on a single decision type.

A verified record has passed a mechanical claim-versus-source check, a second model's read, and human approval. The count is what exists today, not a target.